Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner
- Hawau Abdulsalam
Hawau AbdulsalamDepartment of Chemistry, Wayne State University, Detroit, Michigan 48202, United StatesMore by Hawau Abdulsalam
- ,
- Jiayi Li
Jiayi LiDepartment of Chemistry, Wayne State University, Detroit, Michigan 48202, United StatesMore by Jiayi Li
- ,
- Ravi S. Loka
Ravi S. LokaDepartment of Chemistry, Wayne State University, Detroit, Michigan 48202, United StatesMore by Ravi S. Loka
- ,
- Eric T. Sletten
Eric T. SlettenDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Muehlenberg 1, 14476 Potsdam, GermanyMore by Eric T. Sletten
- , and
- Hien M. Nguyen*
Hien M. NguyenDepartment of Chemistry, Wayne State University, Detroit, Michigan 48202, United StatesMore by Hien M. Nguyen
Abstract
Heparan sulfate-mimicking glycopolymers, composed of glucosamine (GlcN)–glucuronic acid (GlcA) repeating units, bind to the receptor-binding subunit (S1) and spike glycoprotein (S) domains of the SARS-CoV-2 spike protein in a length- and sulfation pattern-dependent fashion. A glycopolymer composed of 12 repeating GlcNS6S-GlcA units exhibits a much higher affinity to the S1 protein (IC50 = 13 ± 1.1 nM) compared with the receptor-binding domain (RBD). This glycopolymer does not interfere in angiotensin-converting enzyme 2 binding of the RBD. Although this compound binds strongly to the S1/membrane-fusion subunit (S2) junction (KD = 29.7 ± 4.18 nM), it does not shield the S1/S2 site from cleavage by furin─a behavior contrary to natural heparin. This glycopolymer lacks iduronic acid, which accounts for 70% of heparin. Further, this compound, unlike natural heparin, is well defined in both sulfation pattern and length, which results in fewer off-target interactions with heparin-binding proteins. The results highlight the potential of using polymeric heparan sulfate (HS) mimetics for the therapeutic agent development.
Cited By
This article has not yet been cited by other publications.